Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Asep Medical Holdings Inc C.ASEP

Alternate Symbol(s):  SEPSF

ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti-microbial, antifouling coating through its SafeCoat Medical Inc. The Company also provides diagnostic kits for predicting the onset of severe Sepsis and organ failure through its Sepset Biosciences Inc. The Company also offers peptide technology through its ABT Innovations Inc. Its technology includes diagnostic and therapeutic. It has developed a novel diagnostic assay for the early and rapid diagnosis of sepsis, based on the detection of molecular signatures of sepsis specific to the immune response, rather than the presence of a pathogen.


CSE:ASEP - Post by User

Asep Medical Holdings Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(144)
•••
Post by culturedpiggy01on Feb 17, 2022 3:48pm
55 Views
Post# 34439401

$ASEP.c provides updates on its antibiofilm peptide tech

$ASEP.c provides updates on its antibiofilm peptide tech

$ASEP.c recently announced that their novel antibiofilm peptide technology is in advanced development via their collaboration with its pre-clinical partner, iFyber, LLC, and grant funding from the US Army Medical Research and Materiel Command https://ca.finance.yahoo.com/news/asep-medical-inc-announces-antibiofilm-130000160.html

The companies are working together to incorporate $ASEP ’s antibiofilm and anti-inflammatory peptide technology into advanced, effective wound dressings to prevent and treat biofilm-associated wounds as well as burn and soft tissue infections

td, $ASEP.c trading at $0.30 with market cap at $16.84 M

 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities